NEKTAR THERAPEUTICSNEKTAR THERAPEUTICSNEKTAR THERAPEUTICS

NEKTAR THERAPEUTICS

No trades
See on Supercharts

Price target

48.340.000.00%
The 3 analysts offering 1 year price forecasts for NKTR have a max estimate of — and a min estimate of —.

Analyst rating

Based on 6 analysts giving stock ratings to NKTR in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


NKTR EPS for the last quarter is −4.59 MXN despite the estimation of −3.39 MXN. In the next quarter EPS is expected to reach −3.96 MXN. Track more of NEKTAR THERAPEUTICS financials and stay on top of what is up with the company.
In the next quarter NEKTAR THERAPEUTICS revenue is expected to reach ‪426.60 M‬ MXN. Check out NEKTAR THERAPEUTICS revenue and earnings and make informed decisions.
According to analysts, NKTR price target is 48.34 MXN with a max estimate of 79.46 MXN and a min estimate of 25.82 MXN. Check if this forecast comes true in a year, meanwhile watch NEKTAR THERAPEUTICS stock price chart and keep track of the current situation with NKTR news and stock market news.
We've gathered opinions of 6 analysts rating NKTR stock in the past 3 months. Most of them backed up the neutral trend, and after taking into account other opinions, the overall rating was calculated as neutral. Note that it's not a trading advice — your own analysis is still required.